A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling.
- DOI
- 10.1186/s12951-026-04899-w
- Published
- 2026 Sep 5
- Container
- Journal of nanobiotechnology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12951-026-04899-w,
title = {A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling.},
author = {E-Y Chuang A and Tung SY and Tzou KY and Cai YE and Hsu HC and Tsui KH and Lin WX and Rethi L and Dong SW and Nguyen HT and Liu CH},
year = {2026},
journal = {Journal of nanobiotechnology},
doi = {10.1186/s12951-026-04899-w},
url = {https://doi.org/10.1186/s12951-026-04899-w}
}RIS
TY - JOUR TI - A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling. AU - E-Y Chuang A AU - Tung SY AU - Tzou KY AU - Cai YE AU - Hsu HC AU - Tsui KH AU - Lin WX AU - Rethi L AU - Dong SW AU - Nguyen HT AU - Liu CH PY - 2026 JO - Journal of nanobiotechnology DO - 10.1186/s12951-026-04899-w UR - https://doi.org/10.1186/s12951-026-04899-w ER -
APA
A, E. C., SY, T., KY, T., YE, C., HC, H., KH, T., WX, L., L, R., SW, D., HT, N., & CH, L. (2026). A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04899-w
Source records
- pubmed · retrieved 2026-09-26T14:58:34.907Z